Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 33.10
- Piotroski Score 6.00
- Grade Outperform
- Symbol (LMAT)
- Company LeMaitre Vascular, Inc.
- Price $103.48
- Changes Percentage (-1.91%)
- Change -$2.02
- Day Low $103.32
- Day High $105.75
- Year High $106.49
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
- Last Earnings 10/31/2024
- Ex-Dividend for 5/16 Dividend 11/21/2024
- Dividend Payable 12/05/2024
- Today N/A
- Next Earnings (Estimated) 02/20/2025
- Fiscal Year End N/A
- Average Stock Price Target $85.50
- High Stock Price Target $100.00
- Low Stock Price Target $70.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $1.51
- Trailing P/E Ratio 51.31
- Forward P/E Ratio 51.31
- P/E Growth 51.31
- Net Income $30.11 M
Income Statement
Quarterly
Annual
Latest News of LMAT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...
Q4 guidance includes 14% sales growth, 68% gross margin, $13.3M operating income, and $0.49 EPS. CEO George LeMaitre addresses OUS price and unit increases and assures sufficient inventory due to no b...
By Yahoo! Finance | 1 week ago -
Man pleads guilty to fatally strangling deaf cellmate in Baltimore jail
A man in Baltimore jail pleaded guilty to killing his deaf cellmate, raising concerns about jail operations and court delays. The victim, Javarick Gantt, was disabled and facing minor charges. The per...
By CBS News | 1 month ago -
After CalMatters investigation, Newsom signs law to shed light on maternity ward closures
Gov. Gavin Newsom signed a law giving communities more time to plan for maternity ward closures in California, as 56 wards have shut since 2012. The new law requires hospitals to notify counties 120 d...
By AP NEWS | 1 month ago
